Patents by Inventor Michael Orth
Michael Orth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260156532Abstract: Aspects of the subject disclosure may include, for example, obtaining first historical data of wireless device communication technologies used to communicate with access points in a first market; obtaining information of a first characteristic of the first market; obtaining second historical data of wireless device communication technologies used to communicate with access points in a second market; obtaining information of a second characteristic of the second market; obtaining third information of a third characteristic of a third market; in a first case that the first characteristic more closely matches the third characteristic, generating based upon the first historical data a first forecast of a first mix of wireless device communication technologies; and in a second case that the second characteristic more closely matches the third characteristic, generating based upon the second historical data a second forecast of a second mix of wireless device communication technologies Other embodiments are disclosType: ApplicationFiled: December 4, 2024Publication date: June 4, 2026Applicant: AT&T Intellectual Property I, L.P.Inventors: Phyllis Weiss, Guang-Qin Ma, Dongyu Lin, Veena Sharma, Meenakshi Kandula, Michael Orth, Charles Howard
-
Publication number: 20260156519Abstract: Aspects of the subject disclosure may include, for example, obtaining first historical data of QoS class identifiers (QCIs) that have been used during communication with access points in a first market; obtaining information of a first characteristic of the first market; obtaining second historical data of QCIs that have been used during communication with access points in a second market; obtaining information of a second characteristic of the second market; obtaining information of a third characteristic of a third market; in a first case that the first characteristic more closely matches the third characteristic, generating based upon the first historical data a first forecast of a first future mix of QCIs; and in a second case that the second characteristic more closely matches the third characteristic, generating based upon the second historical data a second forecast of a second future mix of QCIs. Other embodiments are disclosed.Type: ApplicationFiled: December 4, 2024Publication date: June 4, 2026Applicant: AT&T Intellectual Property I, L.P.Inventors: Phyllis Weiss, Veena Sharma, Meenakshi Kandula, Michael Orth, Guang-Qin Ma, Ajay Shankar, Daniel S. Hoover, Dongyu Lin
-
Patent number: 12507724Abstract: Methods of forming a foam including a tobacco ingredient containing agent and/or an inhalable agent, an aerosol forming agent, a foam stabilizing agent, and a foam forming agent are provided, along with a foam produced by the methods, and foams with a certain aeration, for example of at least 4 vol. % based on the total volume of the foam.Type: GrantFiled: April 26, 2024Date of Patent: December 30, 2025Assignee: JT International SAInventors: Michael Plattner, Michael Orth, Remigius Mastalerz
-
Publication number: 20240277023Abstract: Methods of forming a foam including a tobacco ingredient containing agent and/or an inhalable agent, an aerosol forming agent, a foam stabilizing agent, and a foam forming agent are provided, along with a foam produced by the methods, and foams with a certain aeration, for example of at least 4 vol. % based on the total volume of the foam.Type: ApplicationFiled: April 26, 2024Publication date: August 22, 2024Applicant: JT International S.A.Inventors: Michael Plattner, Michael Orth, Remigius Mastalerz
-
Publication number: 20220265568Abstract: The invention relates to a process for preparing an active-principle-containing adhesive formulation for use in a transdermal therapeutic system, comprising the following steps: a) providing an adhesive formulation containing a carboxylic acid ester-based solvent and a self-adhesive polymer matrix containing monomers of the compounds on which the polymer matrix is based, b) removing the carboxylic acid ester-based solvent and the monomers from the adhesive formulation, c) re-dissolving the compound obtained in step b) in an organic solvent that does not contain any ester groups, and adding a pharmacologically active principle having at least one hydroxyl group, carboxyl group, amino group and/or ester group so that the active-principle-containing adhesive formulation is obtained. The invention also relates to a transdermal therapeutic system containing the active-principle-containing adhesive formulation.Type: ApplicationFiled: July 28, 2020Publication date: August 25, 2022Applicant: LTS LOHMANN THERAPIE-SYSTEME AGInventors: Michael ORTH, Tobias TELLKAMP-SCHEHR, Florian HAMMES, Julia LODDER-GADACZEK
-
Patent number: 11323890Abstract: Aspects of the subject disclosure may include, for example, collecting and storing data about a communication environment including one or more communication networks wherein respective communication networks of the one or more communication networks employ respective communication technologies for communication with remote user devices in the communication environment, providing traffic forecasts of communication traffic, creating importance layers for potential build locations for equipment of the one or more communication networks, identifying desirable build locations among the potential build locations of the one or more communication networks based on the traffic forecasts of communication traffic and the importance layers, receiving user input defining planning parameters for the communication environment and determining respective target goal values for respective build options for the one or more communication networks based on the planning parameters, the identified desirable build locations and theType: GrantFiled: July 10, 2019Date of Patent: May 3, 2022Assignee: AT&T Intellectual Property I, L.P.Inventors: Kathleen Meier-Hellstern, Laurie Bigler, Arun Jotshi, Michael Orth, Phyllis Weiss, Ravi Raina, Wenjie Zhao
-
Patent number: 11253177Abstract: A sensor assembly for detecting at least one analyte in a body fluid includes an electrochemical sensor, a body mount that attaches to a body of a user and an inserter that transfers the sensor to the body mount. A first adhesive is attached to one or both of the body mount or the sensor, and the first adhesive attaches the sensor to the body mount. A second adhesive is attached to one or both of the sensor or the inserter and releasably attaches the sensor to the inserter. The assembly has an initial position in which the sensor is attached to the inserter via the second adhesive and a final position in which the sensor is attached to the body mount via the first adhesive. Transferring the sensor from the initial position to the final position releases the sensor from the inserter.Type: GrantFiled: May 17, 2018Date of Patent: February 22, 2022Assignee: Roche Diabetes Care, Inc.Inventors: Herbert Harttig, Oliver Kube, Michael Orth, Helmut Walter
-
Publication number: 20220031978Abstract: There is provided an aerosol generating device, comprising an inhalation outlet; a chamber for holding a material, the material capable of generating a vapour when heated; a heater for heating material held in the chamber; an air inlet connected by an air inlet passage to the chamber; a vapour-cooling module providing a fluidic connection between the chamber and inhalation outlet, the module configured to cool a vapour passing there through. In use, suction at the inhalation outlet causes air to enter the chamber via the air inlet, thereby transporting the vapour generated in the chamber through the vapour-cooling module to the inhalation outlet, such that the temperature of the vapour exiting the device through the inhalation outlet is substantially lower than the temperature of the vapour generated in the chamber. The aerosol generating device thereby provides a means whereby a vapour generated in the chamber is substantially cooled during transport from the chamber through the mouthpiece to the user.Type: ApplicationFiled: October 19, 2021Publication date: February 3, 2022Applicant: JT International S.A.Inventors: Tatiana Golovanova, Christopher Rory Parsons, Michael Orth, Takashi Hasegawa, Michael Plattner, Thomas Johaentges
-
Publication number: 20210401029Abstract: A method of forming a shaped foam containing a tobacco ingredient containing agent includes a first step of combining and mixing the tobacco ingredient containing agent and a foam forming agent to obtain a first mixture; a second step of adding an aerosol forming agent and optionally a solvent and/or at least one non-tobacco flavoring agent to the first mixture to obtain a second mixture; a third step of adding a foam stabilizing agent to the second mixture to obtain a third mixture; and extruding the third mixture to produce a shaped foam, wherein at least the second and the third step are carried out inside an extruder. A shaped foam containing a tobacco ingredient containing agent produced by the method, and a device for producing shaped foam containing a tobacco ingredient containing agent are also provided.Type: ApplicationFiled: December 17, 2019Publication date: December 30, 2021Applicant: JT International S.A.Inventors: Michael Plattner, Michael Orth, Remigius Mastalerz
-
Patent number: 11173260Abstract: An aerosol generating device, includes an inhalation outlet; a chamber for holding a material, the material capable of generating a vapour when heated; a heater for heating material held in the chamber; an air inlet connected by an air inlet passage to the chamber; a vapour-cooling module providing a fluidic connection between the chamber and inhalation outlet, the module configured to cool a vapour passing there through. Suction at the inhalation outlet causes air to enter the chamber via the air inlet, thereby transporting vapour generated in the chamber through the module to the inhalation outlet, such that the temperature of the vapour exiting the device through the inhalation outlet is substantially lower than the temperature of the vapour generated in the chamber. The device thereby provides a means whereby a vapour generated in the chamber is substantially cooled during transport from the chamber through the mouthpiece to the user.Type: GrantFiled: December 12, 2016Date of Patent: November 16, 2021Inventors: Tatiana Golovanova, Christopher Rory Parsons, Michael Orth, Takashi Hasegawa, Michael Plattner, Thomas Johaentges
-
Publication number: 20210282448Abstract: Methods of forming a foam including a tobacco ingredient containing agent and/or an inhalable agent, an aerosol forming agent, a foam stabilizing agent, and a foam forming agent are provided, along with a foam produced by the methods, and foams with a certain aeration, for example of at least 4 vol. % based on the total volume of the foam.Type: ApplicationFiled: June 28, 2019Publication date: September 16, 2021Applicant: JT International S.A.Inventors: Michael Plattner, Michael Orth, Remigius Mastalerz
-
Publication number: 20210014698Abstract: Aspects of the subject disclosure may include, for example, collecting and storing data about a communication environment including one or more communication networks wherein respective communication networks of the one or more communication networks employ respective communication technologies for communication with remote user devices in the communication environment, providing traffic forecasts of communication traffic, creating importance layers for potential build locations for equipment of the one or more communication networks, identifying desirable build locations among the potential build locations of the one or more communication networks based on the traffic forecasts of communication traffic and the importance layers, receiving user input defining planning parameters for the communication environment and determining respective target goal values for respective build options for the one or more communication networks based on the planning parameters, the identified desirable build locations and theType: ApplicationFiled: July 10, 2019Publication date: January 14, 2021Applicant: AT&T Intellectual Property I, L.P.Inventors: Kathleen Meier-Hellstern, Laurie Bigler, Arun Jotshi, Michael Orth, Phyllis Weiss, Ravi Raina, Wenjie Zhao
-
Patent number: 10424975Abstract: A sensor module (112) for determining a concentration of at least one analyte in a body fluid of a user is disclosed. The sensor module (112) includes at least one sensor element (116) adapted to determine the concentration of the analyte, wherein the sensor element (116) is at least partly implantable into a body tissue of the user; at least one control device (118) connected to the sensor element (116), wherein the control device (118) includes at least one data collection device (122) adapted to collect measurement data acquired by using the sensor element (116). The control device (118) further includes at least one wireless near-field communication device (124) adapted to transmit measurement data. The control device (118) further includes a rechargeable energy storage device (134) and is adapted to transmit at least one demand for recharging the rechargeable energy storage device (134) via the near-field communication device (124).Type: GrantFiled: August 29, 2016Date of Patent: September 24, 2019Assignee: ROCHE DIABETES CARE, INC.Inventors: Oliver Kube, Michael Orth
-
Patent number: 10405885Abstract: A medical applicator and a manipulation unit for use in connection with specific variants of the medical applicator are disclosed. In general, the medical applicator has an insertion needle (108; 308) configured for puncturing a part of a human or animal body (B), a sensor assembly (110; 310) configured to be at least partially inserted into a human or animal body (B) when the body is punctured by said insertion needle (108; 308) and a lifting means (102; 301, 302) for lifting up a surface adjacent portion of the human or animal body (B) towards the insertion needle (108; 308).Type: GrantFiled: August 5, 2015Date of Patent: September 10, 2019Assignee: Roche Diabetes Care, Inc.Inventors: Oliver Kube, Michael Orth, Helmut Walter
-
Publication number: 20180368478Abstract: An aerosol generating device includes an inhalation outlet; a chamber for holding a material, the material capable of generating a vapour when heated; a heater for heating material held in the chamber; an air inlet connected by an air inlet passage to the chamber; a vapour-cooling module providing a fluidic connection between the chamber and inhalation outlet, the module configured to cool a vapour passing there through. Suction at the inhalation outlet causes air to enter the chamber via the air inlet, thereby transporting vapour generated in the chamber through the module to the inhalation outlet, such that the temperature of the vapour exiting the device through the inhalation outlet is substantially lower than the temperature of the vapour generated in the chamber. The device thereby provides a means whereby a vapour generated in the chamber is substantially cooled during transport from the chamber through the mouthpiece to the user.Type: ApplicationFiled: December 12, 2016Publication date: December 27, 2018Applicant: JT International S.A.Inventors: Tatiana Golovanova, Christopher Rory Parsons, Michael Orth, Takashi Hasegawa, Michael Plattner, Thomas Johaentges
-
Publication number: 20180263543Abstract: A sensor assembly for detecting at least one analyte in a body fluid includes an electrochemical sensor, a body mount that attaches to a body of a user and an inserter that transfers the sensor to the body mount. A first adhesive is attached to one or both of the body mount or the sensor, and the first adhesive attaches the sensor to the body mount. A second adhesive is attached to one or both of the sensor or the inserter and releasably attaches the sensor to the inserter. The assembly has an initial position in which the sensor is attached to the inserter via the second adhesive and a final position in which the sensor is attached to the body mount via the first adhesive. Transferring the sensor from the initial position to the final position releases the sensor from the inserter.Type: ApplicationFiled: May 17, 2018Publication date: September 20, 2018Inventors: Herbert Harttig, Oliver Kube, Michael Orth, Helmut Walter
-
Publication number: 20170055890Abstract: A sensor module (112) for determining a concentration of at least one analyte in a body fluid of a user is disclosed. The sensor module (112) includes at least one sensor element (116) adapted to determine the concentration of the analyte, wherein the sensor element (116) is at least partly implantable into a body tissue of the user; at least one control device (118) connected to the sensor element (116), wherein the control device (118) includes at least one data collection device (122) adapted to collect measurement data acquired by using the sensor element (116). The control device (118) further includes at least one wireless near-field communication device (124) adapted to transmit measurement data. The control device (118) further includes a rechargeable energy storage device (134) and is adapted to transmit at least one demand for recharging the rechargeable energy storage device (134) via the near-field communication device (124).Type: ApplicationFiled: August 29, 2016Publication date: March 2, 2017Inventors: Oliver Kube, Michael Orth
-
Publication number: 20160038180Abstract: A medical applicator and a manipulation unit for use in connection with specific variants of the medical applicator are disclosed. In general, the medical applicator has an insertion needle (108; 308) configured for puncturing a part of a human or animal body (B), a sensor assembly (110; 310) configured to be at least partially inserted into a human or animal body (B) when the body is punctured by said insertion needle (108; 308) and a lifting means (102; 301, 302) for lifting up a surface adjacent portion of the human or animal body (B) towards the insertion needle (108; 308).Type: ApplicationFiled: August 5, 2015Publication date: February 11, 2016Inventors: Oliver Kube, Michael Orth, Helmut Walter
-
Publication number: 20120317500Abstract: A non-transitory computer-readable medium stores a program for visualizing data. The program includes code for visualizing data, and code for enabling communication between users of the program.Type: ApplicationFiled: June 7, 2011Publication date: December 13, 2012Applicants: AT&T INTELLECTUAL PROPERTY I, L.P., AT&T MOBILITY II LLCInventors: Mario KOSSEIFI, Syed AFTAB, Michael ORTH
-
Patent number: 8308673Abstract: Methods and devices for selectively removing an agent from a physiological site, e.g., a physiological efferent fluid collection site, are provided. Aspects of the invention include fluid removal (e.g., aspiration) devices having a fluid removal element and a flow modulator positioned at a distal end of the fluid removal element. The flow modulator is configured to converge intersecting fluid flow paths into the fluid removal element. Also provided are systems and kits for performing the subject methods. The subject invention finds use in a variety of different applications, including the selective removal of both therapeutic and diagnostic agents from a variety of different physiological sites.Type: GrantFiled: June 12, 2008Date of Patent: November 13, 2012Assignee: Catharos Medical Systems, Inc.Inventors: Ali Hassan, Lester John Lloyd, Michael Orth, Mark Yang, Binh Luong, Brian K. Courtney, Peter J. Fitzgerald